{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:07:25Z","timestamp":1792822045919,"version":"4.5.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jiac.2016.05.006","type":"journal-article","created":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T13:35:06Z","timestamp":1467034506000},"page":"505-514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":229,"title":["An overview of infectious complications after allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8198-0068","authenticated-orcid":false,"given":"Ugur","family":"Sahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selami Kocak","family":"Toprak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar Ataca","family":"Atilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erden","family":"Atilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taner","family":"Demirer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2016.05.006_bib1","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/annonc\/mdl086","article-title":"Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe","volume":"17","author":"Barkholt","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jiac.2016.05.006_bib2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3324\/haematol.10521","article-title":"Reduced intensity stem cell transplantation for advanced soft tissue sarcomas in adults: a retrospective analysis of the European group for blood and marrow transplantation","volume":"92","author":"Secondino","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.jiac.2016.05.006_bib3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ncponc1104","article-title":"Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors","volume":"5","author":"Demirer","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.jiac.2016.05.006_bib4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbmt.2008.11.036","article-title":"Reduced-intensity allogeneic hematopoietic stem cell transplantation in metastatic colorectal cancer as a novel adoptive cell therapy approach. The European group for blood and marrow transplantation experience","volume":"15","author":"Aglietta","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib5","first-page":"29","article-title":"Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia","volume":"18","author":"Demirer","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib6","first-page":"491","article-title":"Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase i dose escalation of busulfan based on targeted plasma levels","volume":"17","author":"Demirer","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib7","first-page":"341","article-title":"Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase i dose escalation of busulfan based on targeted plasma levels","volume":"17","author":"Demirer","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib8","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/cncr.21477","article-title":"Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation","volume":"104","author":"Peccatori","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jiac.2016.05.006_bib9","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/sj.bjc.6602724","article-title":"Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours","volume":"93","author":"De Giorgi","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jiac.2016.05.006_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.hoc.2010.11.008","article-title":"Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology","volume":"25","author":"Wingard","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jiac.2016.05.006_bib11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/07357907.2014.919301","article-title":"Complications of allogeneic hematopoietic stem cell transplantation","volume":"32","author":"Arnaout","year":"2014","journal-title":"Cancer Investig"},{"key":"10.1016\/j.jiac.2016.05.006_bib12","first-page":"907","article-title":"Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation","volume":"15","author":"Demirer","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib13","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2016.05.006_bib14","article-title":"Prospective evaluation of infection episodes in cancer patients in a tertiary care academic center: microbiological features and risk factors for mortality","author":"Calik Basaran","year":"2016","journal-title":"Turk J Haematol"},{"key":"10.1016\/j.jiac.2016.05.006_bib15","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1086\/374339","article-title":"Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States","volume":"36","author":"Wisplinghoff","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2016.05.006_bib16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/21505594.2016.1156821","article-title":"Bloodstream infections in neutropenic cancer patients: a practical update","volume":"7","author":"Gustinetti","year":"2016","journal-title":"Virulence"},{"key":"10.1016\/j.jiac.2016.05.006_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/sj.bmt.1705040","article-title":"Isolation in the allogeneic transplant environment: how protective is it?","volume":"36","author":"Hayes-Lattin","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10096-007-0397-y","article-title":"Fluoroquinolone prophylaxis in patients with neutropenia: a meta-analysis of randomized placebo-controlled trials","volume":"27","author":"Imran","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2016.05.006_bib19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/QCO.0b013e32834cf054","article-title":"Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients","volume":"24","author":"Bow","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jiac.2016.05.006_bib20","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/sj.bjc.6605270","article-title":"Prevention of febrile neutropenia: use of prophylactic antibiotics","volume":"101","author":"Cullen","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jiac.2016.05.006_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/bmt.2016.66","article-title":"Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation","author":"Weber","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib22","series-title":"Ebmt-esh handbook on haematopoietic stem cell transplantation","first-page":"196","article-title":"Infections after hsct","author":"Rovira","year":"2012"},{"key":"10.1016\/j.jiac.2016.05.006_bib23","first-page":"539","article-title":"Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and il-6 are more reliable than c-reactive protein","volume":"23","author":"von Lilienfeld-Toal","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2016.05.006_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s15010-015-0830-6","article-title":"Biomarker candidates for the detection of an infectious etiology of febrile neutropenia","volume":"44","author":"Richter","year":"2016","journal-title":"Infection"},{"key":"10.1016\/j.jiac.2016.05.006_bib25","first-page":"2863","article-title":"Does procalcitonin, c-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis","volume":"23","author":"Wu","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jiac.2016.05.006_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2141.2001.03083.x","article-title":"Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients","volume":"115","author":"Svaldi","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jiac.2016.05.006_bib27","series-title":"Ebmt-esh handbook on haematopoietic stem cell transplantation","article-title":"Supportive care","author":"Masszi","year":"2012"},{"key":"10.1016\/j.jiac.2016.05.006_bib28","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/bmt.2009.75","article-title":"Optimal use of g-csf administration after hematopoietic sct","volume":"43","author":"Trivedi","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib29","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.2014.60.5121","article-title":"Effect of granulocyte-macrophage colony-stimulating factor on prevention and treatment of invasive fungal disease in recipients of allogeneic stem-cell transplantation: a prospective multicenter randomized phase iv trial","volume":"33","author":"Wan","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jiac.2016.05.006_bib30","series-title":"Ebmt-esh handbook on haematopoietic stem cell transplantation","first-page":"176","article-title":"Early complications after hsct","author":"Carreras","year":"2012"},{"key":"10.1016\/j.jiac.2016.05.006_bib31","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the transplant-associated infection surveillance network (transnet) database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2016.05.006_bib32","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/1469-0691.12002","article-title":"Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in brazil","volume":"19","author":"Nucci","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2016.05.006_bib33","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bbmt.2014.03.004","article-title":"Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the gruppo italiano trapianto midollo osseo (gitmo)","volume":"20","author":"Girmenia","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MOH.0000000000000086","article-title":"Epidemiology and risk factors for invasive fungal diseases in hematopoietic stem cell transplantation","volume":"21","author":"Girmenia","year":"2014","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jiac.2016.05.006_bib35","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2002-05-1496","article-title":"Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors","volume":"100","author":"Marr","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2016.05.006_bib36","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1093\/clinids\/22.Supplement_2.S73","article-title":"The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside","volume":"22","author":"Cole","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2016.05.006_bib37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00277-003-0666-5","article-title":"Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin b solution","volume":"82","author":"Lass-Florl","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jiac.2016.05.006_bib38","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.bbmt.2013.05.018","article-title":"Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience","volume":"19","author":"Omer","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib39","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/imj.12595","article-title":"Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation","volume":"44","author":"Fleming","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.jiac.2016.05.006_bib40","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMe068266","article-title":"Prophylaxis and aspergillosis \u2013 has the principle been proven?","volume":"356","author":"De Pauw","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2016.05.006_bib41","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/imj.12596","article-title":"Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy","volume":"44","author":"Morrissey","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.jiac.2016.05.006_bib42","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbmt.2014.02.018","article-title":"Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by gruppo italiano trapianto midollo osseo (gitmo)","volume":"20","author":"Girmenia","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib43","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2016.05.006_bib44","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2016.05.006_bib45","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood.V96.6.2055","article-title":"Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial","volume":"96","author":"Marr","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2016.05.006_bib46","unstructured":"Merck Sharp, Dohme C. Noxafil\u00ae prescribing information. In: Corporation MSD, editor. Noxafil\u00ae prescribing information."},{"key":"10.1016\/j.jiac.2016.05.006_bib47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1399-3062.2009.00455.x","article-title":"Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation","volume":"12","author":"Martin","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jiac.2016.05.006_bib48","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2141.2011.08838.x","article-title":"Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation","volume":"155","author":"Marks","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jiac.2016.05.006_bib49","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1182\/blood-2003-08-2644","article-title":"Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants","volume":"103","author":"Marr","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2016.05.006_bib50","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/TP.0b013e3182577485","article-title":"Comparison of posaconazole versus weekly amphotericin b lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation","volume":"94","author":"Chaftari","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.jiac.2016.05.006_bib51","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5144\/1658-3876.2010.167","article-title":"Once-weekly liposomal amphotericin b for prophylaxis of invasive fungal infection after graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: a comparative retrospective single-center study","volume":"3","author":"El Cheikh","year":"2010","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.jiac.2016.05.006_bib52","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2016.05.006_bib53","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/1040841X.2013.804033","article-title":"Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with pcr for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis","volume":"41","author":"Heng","year":"2015","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.jiac.2016.05.006_bib54","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/cid\/cit393","article-title":"The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis","volume":"57","author":"Fisher","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2016.05.006_bib55","first-page":"520","article-title":"False-positive aspergillus galactomannan and its kinetics in allogeneic hematopoietic stem cell transplantation","volume":"70","author":"Kimura","year":"2015","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jiac.2016.05.006_bib56","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2016.05.006_bib57","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/imj.12598","article-title":"Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation","volume":"44","author":"Blyth","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.jiac.2016.05.006_bib58","first-page":"453","article-title":"Clinical epidemiology of 960 patients with invasive aspergillosis from the path alliance registry","volume":"65","author":"Steinbach","year":"2012","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jiac.2016.05.006_bib59","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/annonc\/mdl044","article-title":"High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults","volume":"17","author":"Pedrazzoli","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jiac.2016.05.006_bib60","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1200\/JCO.2010.32.5936","article-title":"High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials","volume":"29","author":"Berry","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jiac.2016.05.006_bib61","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1038\/bmt.2008.69","article-title":"28 years of high-dose therapy and sct for neuroblastoma in Europe: lessons from more than 4000 procedures","volume":"41","author":"Ladenstein","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib62","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin b for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2016.05.006_bib63","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1111\/j.1439-0507.2010.01947.x","article-title":"Efficacy outcomes in a randomised trial of liposomal amphotericin b based on revised eortc\/msg 2008 definitions of invasive mould disease","volume":"54","author":"Cornely","year":"2011","journal-title":"Mycoses"},{"key":"10.1016\/j.jiac.2016.05.006_bib64","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/bmt.2009.334","article-title":"Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European organisation for research and treatment of cancer study","volume":"45","author":"Herbrecht","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib65","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis: a randomized trial","volume":"162","author":"Marr","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2016.05.006_bib66","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1399-0012.2005.00346.x","article-title":"Is pneumocystis carinii pneumonia after stem cell transplantations a contagious disease?","volume":"19","author":"Resnick","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib67","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.bmt.1705149","article-title":"Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study","volume":"36","author":"De Castro","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib68","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/bmt.2010.335","article-title":"Low-dose trimethoprim-sulfamethoxazole for pneumocystis jiroveci pneumonia prophylaxis after allogeneic hematopoietic sct","volume":"46","author":"Muto","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib69","first-page":"1057","article-title":"Late onset pneumocystis carinii pneumonia following allogeneic bone marrow transplantation","volume":"17","author":"Lyytikainen","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib70","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.bmt.1701902","article-title":"Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation","volume":"24","author":"Demirer","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib71","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/sj.bmt.1704291","article-title":"Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients","volume":"32","author":"Kroger","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib72","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/bmt.2009.254","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective","volume":"44","author":"Center for International B","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1439-0507.2010.01985.x","article-title":"Caspofungin plus posaconazole as salvage therapy of invasive fungal infections in immunocompromised patients","volume":"54","author":"Lellek","year":"2011","journal-title":"Mycoses"},{"key":"10.1016\/j.jiac.2016.05.006_bib74","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1086\/423381","article-title":"Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy","volume":"39","author":"Maertens","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2016.05.006_bib75","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.bmt.1704153","article-title":"Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European group for blood and marrow transplantation (ebmt) registry 1990\u20131999","volume":"32","author":"Pedrazzoli","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib76","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin b-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2016.05.006_bib77","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jac\/dkr375","article-title":"The deferasirox-ambisome therapy for mucormycosis (defeat mucor) study: a randomized, double-blinded, placebo-controlled trial","volume":"67","author":"Spellberg","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2016.05.006_bib78","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/MD.0000000000000008","article-title":"Fusarium infection: report of 26 cases and review of 97 cases from the literature","volume":"92","author":"Muhammed","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jiac.2016.05.006_bib79","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2010.175","article-title":"European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ecil 3--2009 update","volume":"46","author":"Maertens","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib80","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/tid.12118","article-title":"Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Kawamura","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jiac.2016.05.006_bib81","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/bmt.2008.386","article-title":"Management of hsv, vzv and ebv infections in patients with hematological malignancies and after sct: guidelines from the second European conference on infections in leukemia","volume":"43","author":"Styczynski","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib82","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7326\/0003-4819-118-3-199302010-00003","article-title":"Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant","volume":"118","author":"Goodrich","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2016.05.006_bib83","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/0003-4819-118-3-199302010-00004","article-title":"Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial","volume":"118","author":"Winston","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2016.05.006_bib84","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJM199104113241501","article-title":"A\u00a0randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; the city of hope-stanford-syntex cmv study group","volume":"324","author":"Schmidt","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2016.05.006_bib85","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/infdis\/166.3.473","article-title":"Phase i-ii trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients","volume":"166","author":"Reusser","year":"1992","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2016.05.006_bib86","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/bmt.2009.258","article-title":"Viral disease prevention after hematopoietic cell transplantation","volume":"44","author":"Zaia","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib87","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood.V99.4.1159","article-title":"Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation","volume":"99","author":"Reusser","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2016.05.006_bib88","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bbmt.2005.12.038","article-title":"Pharmacokinetics of ganciclovir after oral valganciclovir versus intravenous ganciclovir in allogeneic stem cell transplant patients with graft-versus-host disease of the gastrointestinal tract","volume":"12","author":"Winston","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib89","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/sj.bmt.1705341","article-title":"Valganciclovir is safe and effective as pre-emptive therapy for cmv infection in allogeneic hematopoietic stem cell transplantation","volume":"37","author":"Ayala","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib90","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood.V97.2.388","article-title":"Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The infectious diseases working party of the European group for blood and marrow transplantation","volume":"97","author":"Ljungman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2016.05.006_bib91","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1473-3099(11)70024-X","article-title":"Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial","volume":"11","author":"Marty","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2016.05.006_bib92","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood-2002-03-0993","article-title":"Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and t-cell immunity","volume":"101","author":"Boeckh","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2016.05.006_bib93","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1086\/515146","article-title":"Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients","volume":"28","author":"Nguyen","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2016.05.006_bib94","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/jmv.21096","article-title":"Monitoring of epstein-barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease","volume":"80","author":"Meerbach","year":"2008","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jiac.2016.05.006_bib95","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V92.5.1549.417k32_1549_1555","article-title":"Infusion of cytotoxic t cells for the prevention and treatment of epstein-barr virus-induced lymphoma in allogeneic transplant recipients","volume":"92","author":"Rooney","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2016.05.006_bib96","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cid\/cit358","article-title":"Human herpesvirus 6 (hhv-6) reactivation and hhv-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study","volume":"57","author":"Ogata","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2016.05.006_bib97","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3324\/haematol.2009.016758","article-title":"Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of bk virus infection, preparative regimen intensity and donor type","volume":"95","author":"Silva Lde","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jiac.2016.05.006_bib98","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/tid.12455","article-title":"Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients","volume":"17","author":"Ruggeri","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jiac.2016.05.006_bib99","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3904\/kjim.2015.30.2.212","article-title":"Treatment of bk virus-associated hemorrhagic cystitis with low-dose intravenous cidofovir in patients undergoing allogeneic hematopoietic cell transplantation","volume":"30","author":"Lee","year":"2015","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jiac.2016.05.006_bib100","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bbmt.2015.12.009","article-title":"Cidofovir in the treatment of bk virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Philippe","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib101","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.antiviral.2015.02.002","article-title":"Effect of leflunomide, cidofovir and ciprofloxacin on replication of bkpyv in a salivary gland in\u00a0vitro culture system","volume":"118","author":"Jeffers-Francis","year":"2015","journal-title":"Antivir Res"},{"key":"10.1016\/j.jiac.2016.05.006_bib102","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.bbmt.2010.12.700","article-title":"Efficacy and safety of ciprofloxacin for prophylaxis of polyomavirus bk virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients","volume":"17","author":"Miller","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jiac.2016.05.006_bib103","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000345852","article-title":"Efficacy and safety of leflunomide for the treatment of bk virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients","volume":"130","author":"Chen","year":"2013","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jiac.2016.05.006_bib104","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/INF.0000000000000407","article-title":"Effective treatment of severe bk virus-associated hemorrhagic cystitis with leflunomide in children after hematopoietic stem cell transplantation: a pilot study","volume":"33","author":"Wu","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2016.05.006_bib105","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s12185-015-1832-y","article-title":"The use of hyperbaric oxygen therapy in the treatment of hemorrhagic cystitis after allogeneic stem cell transplantation from an unrelated donor","volume":"102","author":"Urbaniak-Kujda","year":"2015","journal-title":"Int J Hematol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X16300769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X16300769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:55:26Z","timestamp":1761159326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X16300769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":105,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1341321X16300769"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2016.05.006","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An overview of infectious complications after allogeneic hematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2016.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}